A detailed history of Accordant Advisory Group Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Accordant Advisory Group Inc holds 1,816 shares of EW stock, worth $167,653. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,816
Holding current value
$167,653
% of portfolio
0.13%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$72.54 - $95.56 $131,732 - $173,536
1,816 New
1,816 $174 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $57.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Accordant Advisory Group Inc Portfolio

Follow Accordant Advisory Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accordant Advisory Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Accordant Advisory Group Inc with notifications on news.